article thumbnail

Merck Invests $90M In San Diego Research Group

socalTECH

Biopharmaceuticals giant Merck said today that it is investing $90M in setting up a new, San Diego research organization, called Calibr. According to Merck, the new, independent not-for-profit will aim to accelerate translation of basic biomedical research into new medicines to treat disease, and will be led by Peter G.

San Diego 140
article thumbnail

Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in

Xconomy

Our new podcast packages the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine & Genomics forum. How has the investment paradigm shift in funding strategies impacted San Diego? Listen today. What does the future hold for.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

San Diego Tech Roundup: Ezoic, Trust & Will, Oska Wellness & More

Xconomy

Summer can be a slow time in San Diego, but its startups have stayed busy. Sageview Capital, an investment firm with offices in Palo Alto, CA, and in Greenwich, CT, was the lone investor that participated in the deal. Based in Carlsbad, in northern San Diego County, Ezoic launched its platform in 2011.

article thumbnail

Nanome Picks Up $3M

socalTECH

San Diego-based virtual reality startup Nanome, which is developing technology to help researchers explore the interaction of molecules and molecular compounds using VR, has raised $3M in a funding round, the company disclosed today.

San Diego 113
article thumbnail

BioDuro Acquired By Advent International

socalTECH

San Diego-based BioDuro , a life sciences contract research and development organization, has been acquired by private equity investor Advent International , the companies said over the weekend. Financial details of the majority, strategic investment in BioDuro were not announced. READ MORE>>.

article thumbnail

Aardvark Therapeutics Gets $29M In Series B

socalTECH

San Diego-based Aardvark Therapeutics, a biopharmaceuticals company focused on metabolic diseases, said this morning that it has raised $29M in its Series B funding round. The company said the funding will go towards three Phase 2 clinical trails of its lead compound, and to advance several potential additional formulations.

San Diego 140
article thumbnail

Sorrento Therapeutics Gets Strategic Investment From NantWorks

socalTECH

San Diego-based oncology drug developer Sorrento Therapeutics has scored a strategic investment from NantWorks , the biotech research company led by Dr. Patrick Soon-Shiong. sorrento therapeutics nantworks biotech lifescience venture capital strategic investment cancer immunotherapy' READ MORE>>.

Invest 147